VivoSeq
Other

Randomised Controlled Trial

0

Pipeline Programs

7

Active Trials

1

Companies Involved

Randomised Controlled Trial is an early-stage landscape with 0 programs across 1 company. The most active players are S.L.A. Pharma AG.

Pipeline Metrics

Competitive Density

22/100

Pipeline Velocity

15/100

Mech. Concentration

N/A

Completion Rate

90/100

Attrition Rate

6/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

33

clinical trials

Completed18 · 55%
Unknown status6 · 18%
Recruiting4 · 12%
Terminated2 · 6%
Not yet recruiting2 · 6%
Active, not recruiting1 · 3%

Trial Activity

33 trials

Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)